Related Experiment Videos

Paradoxical embolism in a boy with cystic fibrosis and a stroke

S D Playfor1, A R Smyth

  • 1Department of Paediatrics, Neonatal Intensive Care Unit, Queen's Medical Centre, Nottingham NG7 2UH, UK.

Thorax
|November 24, 1999
PubMed

Insights

A stroke in a cystic fibrosis patient was caused by a blood clot from a venous access device traveling through a heart defect. Closing the heart defect resolved the stroke symptoms, marking the first reported paradoxical embolism linked to such devices.

Area of Science:

  • Cardiology
  • Neurology
  • Pediatrics

Background:

  • Cystic fibrosis (CF) patients face increased risks for thromboembolic events.
  • Totally implantable venous access devices (Port-a-Cath) are common in CF patients for treatment delivery.
  • Paradoxical embolism, where a clot travels from venous to arterial circulation, is a rare but serious complication.

Observation:

  • An 11-year-old boy with CF experienced a stroke (right-sided weakness) secondary to a Port-a-Cath insertion four years prior.
  • Magnetic resonance angiography revealed a left middle cerebral artery filling defect.
  • Transesophageal echocardiography identified a thrombus on the Port-a-Cath tip and a patent foramen ovale.

Findings:

  • The patient underwent anticoagulation followed by transcatheter closure of the patent foramen ovale using a septal occlusion device.
  • Neurological deficits completely resolved post-intervention.
  • No further thromboembolic events occurred during follow-up.

Implications:

  • This case highlights a novel mechanism of stroke in a pediatric CF patient, involving a Port-a-Cath-associated thrombus and patent foramen ovale.
  • It underscores the importance of considering paradoxical embolism in young patients with venous access devices and unexplained neurological events.
  • Transcatheter closure of a patent foramen ovale can be an effective treatment to prevent recurrent paradoxical emboli.

Related Concept Videos